Dr. Takigawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Baylor Plaza
Houston, TX 77030
Education & Training
Baylor College of MedicineInternship, Internal Medicine/Pediatrics, 2022 - 2026
Texas Tech University Health Sciences Center Paul L. Foster School of MedicineClass of 2022
Awards, Honors, & Recognition
- Gold Humanism Honor Society Paul L. Foster School of Medicine, 2022
Publications & Presentations
PubMed
- The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity.Jay Shah, Andres Caleb Urias Rivera, Irene Jeong-Ah Lee, Kei Takigawa, Antony Mathew
American Journal of Clinical Oncology. 2024-10-30 - Gastrointestinal toxicities of proteasome inhibitor therapy.Jay Shah, Samanthika Devalaraju, Elliot Baerman, Irene Jeong-Ah Lee, Kei Takigawa
Journal of Cancer Research and Clinical Oncology. 2024-07-05 - 3 citationsThe Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy.Yae Kye, Lokesh Nagineni, Shrikanth Gadad, Fabiola Ramirez, Hannah Riva
Cancers. 2022-08-31
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
